Skip to main content
CLBTCellebrite DI Ltd.Sell6.0·$12.98+1.09%
Open full analysis

Cellebrite DI Ltd. (CLBT) Stock Analysis

SellVALUE-TRAP 1/5Moderate Confidence

Technology · Software - Infrastructure

Sell if holding. Momentum 1.6/10 is below the 5.0 floor at $12.98 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 4.5): -1.5; Negative momentum.

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt,... Read more

$12.98+42.3% A.UpsideScore 6.0/10#24 of 77 Software - Infrastructure
QualityF-score8 / 9FCF yield4.67%
Stop $12.03Target $18.27(analyst − 13%)A.R:R 3.5:1
Analyst target$21.00+61.8%7 analysts
$18.27our TP
$12.98price
$21.00mean
$28

Sell if holding. Momentum 1.6/10 is below the 5.0 floor at $12.98 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 4.5): -1.5; Negative momentum. Chart setup: No clear chart pattern; technical signals are mixed. Score 6.0/10, moderate confidence.

Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 67d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-15
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 20, 202667d to earnings· next earnings call

Thesis

Rewards
Strong growth profile
Analyst upside: 42%
Risks
Leverage penalty (D/E 4.5): -1.5
Negative momentum
Below 200-MA, MA slope -1.1%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)45.9
P/E (Fwd)19.4
Mkt Cap$3.2B
EV/EBITDA34.7
Profit Mgn14.5%
ROE16.4%
Rev Growth19.3%
Beta1.17
DividendNone
Rating analysts14

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.09bullish
IV81%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker·1 ceiling hit

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Volume
0.5
Macd
0.9
Obv
1.0
Ma Position
1.0
Rsi
4.5
Volume distribution (falling OBV)Below 200-MA, MA slope -1.1%/30d — confirmed downtrend
GatesMomentum 1.6<4.5Death cross (50MA < 200MA)A.R:R 3.5 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 67d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
48 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $12.40Resistance $16.11

Price Targets

$12
$18
A.Upside+40.8%
A.R:R3.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! momentum at 1.6 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-20 (67d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLBT stock a buy right now?

Sell if holding. Momentum 1.6/10 is below the 5.0 floor at $12.98 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 4.5): -1.5; Negative momentum. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $12.03. Score 6.0/10, moderate confidence.

What is the CLBT stock price target?

Take-profit target: $18.27 (+42.3% upside). Prior stop was $12.03. Stop-loss: $12.03.

What are the risks of investing in CLBT?

Leverage penalty (D/E 4.5): -1.5; Negative momentum; Below 200-MA, MA slope -1.1%/30d (confirmed downtrend).

Is CLBT overvalued or undervalued?

Cellebrite DI Ltd. trades at a P/E of 45.9 (forward 19.4). TrendMatrix value score: 6.3/10. Verdict: Sell.

What do analysts say about CLBT?

14 analysts cover CLBT with a consensus score of 4.1/5. Average price target: $21.

What does Cellebrite DI Ltd. do?Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East,...

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Related stocks: PICS (PicS N.V.) · GCT (GigaCloud Technology Inc) · DLO (DLocal Limited) · KSPI (Joint Stock Company Kaspi.kz - ) · RELY (Remitly Global, Inc.)
Home Stocks CLBT

Latest news

Latest News

TipRanks34d ago
Marketscreener.com40d agoFda Decision
Stock Titan40d ago
MSN32d agoEarnings
Quiver Quantitative32d agoEarnings
Marketscreener.com32d agoEarnings
Marketscreener.com32d agoEarnings
Marketscreener.com32d agoEarnings
TipRanks33d ago
Yahoo Finance37d ago
Simplywall.st38d ago
Benzinga19d ago
Benzinga31d agoAnalyst
Benzinga32d agoEarnings
Benzinga32d agoEarnings
Benzinga32d agoEarnings
Benzinga32d agoEarnings
Benzinga32d ago
Benzinga40d agoProduct
Benzinga45d ago